These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6219798)

  • 1. [Therapeutic discussion of 98 cases of thromboangiitis obliterans phase III, stages 2 to 3].
    Gu YF
    Zhong Xi Yi Jie He Za Zhi; 1982 Jan; 2(1):29-31. PubMed ID: 6219798
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on hematologic parameters in thromboangiitis obliterans of the blood stasis syndrome].
    Zheng P
    Zhong Xi Yi Jie He Za Zhi; 1986 Jun; 6(6):332-5, 323. PubMed ID: 2430727
    [No Abstract]   [Full Text] [Related]  

  • 3. A report on the use of pulvis resinae in the treatment of thromboangiitis obliterans.
    Zhu BG; Sun YY; Liu TP; Gao CZ; Feng LZ; Dong YF
    J Tradit Chin Med; 1985 Dec; 5(4):237-9. PubMed ID: 3834234
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new combined therapy of intra-arterial drug injection and oral traditional Chinese medicines in treatment of thromboangiitis obliterans (author's transl)].
    Chen ZQ
    Zhonghua Wai Ke Za Zhi; 1981 Sep; 19(9):558-60. PubMed ID: 7338116
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboangiitis obliterans.
    Brown H; Sellwood RA; Harrison CV; Martin P
    Br J Surg; 1969 Jan; 56(1):59-63. PubMed ID: 5766322
    [No Abstract]   [Full Text] [Related]  

  • 6. THROMBOANGIITIS OBLITERANS AND ARTERIOSCLEROSIS OBLITERANS. CLINICAL AND PROGNOSTIC DIFFERENCES.
    MCPHERSON JR; JUERGENS JL; GIFFORD RW
    Ann Intern Med; 1963 Sep; 59():288-96. PubMed ID: 14065946
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of thromboangiitis obliterans with arterialization of the venous channel.
    Pei YK; Lin MS; Jiang ZY; Wang XW
    Chin Med J (Engl); 1985 Nov; 98(11):787-92. PubMed ID: 3938707
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical analysis of 200 cases of necrotic thromboangiitis obliterans].
    Zhao XD; Jin X
    Zhong Xi Yi Jie He Za Zhi; 1990 Dec; 10(12):729-31, 709. PubMed ID: 1705484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental-surgical aspect of Buerger's disease and its hyperpyretic therapy. Clinical experiences with partial salvage amputation of the lower limbs on a demarcation zone in Buerger's disease].
    Kaufer L; Grin E; Prcić M; Bosković S; Atijas A; Stipancević L
    Med Arh; 1974; 28(4):369-75. PubMed ID: 4444348
    [No Abstract]   [Full Text] [Related]  

  • 10. Penile amputation in Buerger's disease-an unusual cause of organ loss.
    Orhan I; Onur R; Akpolat N; Semercioz A
    Scand J Urol Nephrol; 2004; 38(2):188-9. PubMed ID: 15204418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboangiitis Obliterans Biomarker Shifts in Different Acute Phase Stages: A Case Study.
    Hofmann GA; Zierfuss B; Koppensteiner R; Willfort-Ehringer A; Kopp C
    Ann Vasc Surg; 2021 May; 73():509.e5-509.e9. PubMed ID: 33333192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of thromboangiitis obliterans by arterialization of the venous channel].
    Pei YK; Jiang ZY; Wang XW
    Zhonghua Wai Ke Za Zhi; 1984 Dec; 22(12):741-4, 782. PubMed ID: 6543756
    [No Abstract]   [Full Text] [Related]  

  • 13. Traditional chinese medicine in the treatment of thromboangiitis obliterans. Report of 136 cases.
    Chinas Med; 1968 Jan; 1():54-64. PubMed ID: 5678364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental--surgical aspect of Buerger's disease and its treatment using hyperpyretic therapy 3--histopathological analysis of the limbs in experimental gangrene].
    Kaufer L; Prcić M; Svob M; Bosković S; Atijas A; Stipancević L
    Med Arh; 1974; 28(2):161-5. PubMed ID: 4846808
    [No Abstract]   [Full Text] [Related]  

  • 15. DIAGNOSIS AND TREATMENT OF THROMBOANGIITIS OBLITERANS.
    ABRAMSON DI
    Geriatrics; 1965 Jan; 20():28-41. PubMed ID: 14249985
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE VALUE OF NEURO-ENDOCRINE SURGERY IN THE TREATMENT OF THROMBOANGIITIS. PHYSIOPATHOLOGICAL BASES, INDICATIONS, LIMITATIONS, TECHNICS. RESULTS].
    MANDACHE F; PRODESCU V; CONSTANTINESCU S; KOVER G; MATEESCU D
    Minerva Cardioangiol; 1964 Apr; 12():163-6. PubMed ID: 14146091
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thromboangiitis obliterans].
    Sredina GG
    Voen Med Zh; 1978 Oct; (10):75-7. PubMed ID: 706210
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue.
    Paraskevas KI
    Clin Rheumatol; 2008 Apr; 27(4):547. PubMed ID: 18246380
    [No Abstract]   [Full Text] [Related]  

  • 19. A Non-smoking Woman with Anti-phospholipid Antibodies Proved to Have Thromboangiitis Obliterans.
    Shima N; Akiyama Y; Yamamoto S; Kokuzawa A; Nagatani K; Iwamoto M; Matsubara D; Kawai S; Sato K; Minota S
    Intern Med; 2020 Feb; 59(3):439-443. PubMed ID: 31588083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease).
    Cooper LT; Tse TS; Mikhail MA; McBane RD; Stanson AW; Ballman KV
    J Am Coll Cardiol; 2004 Dec; 44(12):2410-1. PubMed ID: 15607407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.